Improving global health depends on focused and effective research.
MediBeacon is focused on technology advances that make the use of fluorescent tracer agent-based transdermal measurement systems an important factor in the delivery of superior medical care.
The objectives are to aid in the understanding of disease and the development of interventions which can slow or arrest disease progression. More efficient research holds the promise of improving the likelihood that the most effective and appropriate treatments are available to patients as soon as possible.
Slowing the progression to End Stage Renal Disease (ESRD) is critical to prolonging human lifespan and improving the quality of life for those who are either susceptible to kidney disease or who have kidney disease.
Chronic kidney disease often develops slowly and with few symptoms. Many people don’t realize they’re sick until the disease is advanced.
There is growing research that connects abnormal gastrointestinal permeability to specific inflammatory bowel diseases. Peer-reviewed publications have continued to increase exponentially in this area. In 2018 alone, there were over 800 peer-reviewed publications.
Increasing evidence points to abnormal gut permeability as a “leading indicator” of inflammation.
- BMC Gastroenterology, Stephan Bischoff et al.,
Intestinal permeability - a new target for disease prevention and therapy, 2014
Ureteral injury is one of the most serious complications of gynecologic surgery. Ureteral injuries are often associated with significant morbidity, especially when recognized postoperatively. Injuries to the urinary tract are the most common cause for legal action against gynecologic surgeons.
- Medscape Reference, Sandip P Vasavada, MD et al.,
Ureteral injury during gynecologic surgery, March 13, 2013
The use of fluorescent tracer agent-based systems has the potential to aid in the mitigation of serious complications during gynecologic and other abdominal surgeries.